Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Iovance Biotherapeutics (IOVA) Leases (2019 - 2025)

Historic Leases for Iovance Biotherapeutics (IOVA) over the last 4 years, with Q3 2025 value amounting to $48.8 million.

  • Iovance Biotherapeutics' Leases changed N/A to $48.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $48.8 million, marking a year-over-year change of. This contributed to the annual value of $55.2 million for FY2024, which is 1169.96% down from last year.
  • As of Q3 2025, Iovance Biotherapeutics' Leases stood at $48.8 million.
  • Iovance Biotherapeutics' Leases' 5-year high stood at $71.5 million during Q1 2024, with a 5-year trough of $48.8 million in Q3 2025.
  • For the 3-year period, Iovance Biotherapeutics' Leases averaged around $60.4 million, with its median value being $62.5 million (2023).
  • Its Leases has fluctuated over the past 5 years, first soared by 154.05% in 2024, then plummeted by 2882.29% in 2025.
  • Over the past 3 years, Iovance Biotherapeutics' Leases (Quarter) stood at $62.5 million in 2023, then decreased by 11.7% to $55.2 million in 2024, then fell by 11.66% to $48.8 million in 2025.
  • Its last three reported values are $48.8 million in Q3 2025, $49.9 million for Q2 2025, and $50.9 million during Q1 2025.